Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.20 (overall 0.12) | 0.20 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 27 Parkinson's papers of 246 | 0.56 |
| pathways Reactome | 9 pathways; mostly lysosome and autophagy | 1.00 |
No case: the score is under the bar. Receipt 2309
Sealed predictions
- CHMP2B in dopamine neurons, braak+0.76 (p 0.018) → +0.25 (p 0.514)receipt 2316
Swarm cases
receipt 2316: CHMP2B in dopamine neurons, braak
- power
- full sample +0.61 (p 0.0077, n 18), 95% CI +0.19 to +0.84. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.56 (p 0.015, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.66 (p 0.0031, n 18). not the mix.
- skeptic
- leave-one-out range +0.56 to +0.72, sign flips 0; without severely affected donors +0.61 (p 0.0077, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CHMP2B in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts